Roberto Clemente was beloved across country and MLB lines during his life in the spotlight. Much to one fan’s dismay, that doesn’t make Clemente an official saint. Vatican officials denied a rumor that had picked up steam in recent weeks claiming Pope Francis had “blessed” Clemente, the Washington Post reported Thursday. The spokespeople said they...
NYS Entity Status
NYS Filing Date
MAY 09, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL CORPORATION
2014 - CLEMENTE PHYSICAL THERAPY P.C.
Around the Web
- The complicated battle over Roberto Clemente’s sainthood
By Hannah Withiam - Thursday Aug 17, 2017
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
- FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
By Ben Fidler - Tuesday Aug 29, 2017
The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]
- Mt. Sinai's new therapy dog is a mutt with a mission
By Peter D'Amato - Thursday Aug 10, 2017
Midway through his shift at Mount Sinai’s Kravis Children’s Hospital, the health system’s youngest worker was doing his rounds—on four legs. Professor Bunsen...
To view the full story, click the title link.
- For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY
By Ben Fidler - Wednesday Aug 9, 2017
A drug that actually slows or reverses the brain damage inflicted by Parkinson’s disease, rather than just alleviates its often debilitating symptoms, remains elusive. But Prevail Therapeutics, a startup just launched in New York, has become the latest to try. This morning, the Silverstein Foundation, a nonprofit organization formed by OrbiMed partner Jonathan Silverstein, announced […]